Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> Charts linked in article comparing the current HCV meds
Post Info TOPIC: Charts linked in article comparing the current HCV meds
LC


Senior Member

Status: Offline
Posts: 473
Date:
RE: Charts linked in article comparing the current HCV meds
Permalink  
 

I hope not, but I wouldn't be at all surprised if that happens.  Insurance is a business.  It was interesting to see that the Abbvie combo I am currently on is actually the most effective one for my treatment naïve 1a group.

If I had to choose a treatment, based on what I know now about effectiveness and side effects of this Abbvie combo, I would pick Abbvie. I'm not on any other meds to be worried about possible interactions and I really don't care if I take 5 pills in the am and 4 in the pm as opposed to 1, these side effects are very minor (IMO and so far) and I want my best chance for SVR. 



__________________

Genotype 1a, VL 1,151,923.  51 years old.  Started treatment on AbbVie TOPAZ II clinical trial Oct 10, 2014!  Undetected at weeks 2 and 4! 
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Thanks LC,

That was an interesting article and comparison. The chart shows how close these protocols truly are in effectiveness. A big improvement to what we just lived through! It's going to be worth watching the providers and their reaction. I hope we don't witness increased limitations to protocols based strictly on price. 

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
LC


Senior Member

Status: Offline
Posts: 473
Date:
Permalink  
 

I had been looking for a chart comparing the current meds, and I ran across one in case anyone else is interested.

http://www.marketwired.com/press-release/move-over-gilead-abbvie-could-bring-serious-competition-to-hcv-market-1956910.htm

 



__________________

Genotype 1a, VL 1,151,923.  51 years old.  Started treatment on AbbVie TOPAZ II clinical trial Oct 10, 2014!  Undetected at weeks 2 and 4! 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> Charts linked in article comparing the current HCV meds
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.